BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10443562)

  • 1. Antidepressants for the new millennium.
    Skolnick P
    Eur J Pharmacol; 1999 Jun; 375(1-3):31-40. PubMed ID: 10443562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine neurocircuitry in depression and strategies for new treatments.
    Hamon M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of co-administration of varenicline and antidepressants on extracellular monoamine concentrations in rat prefrontal cortex.
    Rollema H; Wilson GG; Lee TC; Folgering JH; Flik G
    Neurochem Int; 2011 Jan; 58(1):78-84. PubMed ID: 21056607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain. A quantitative in situ hybridization study.
    Boyer PA; Skolnick P; Fossom LH
    J Mol Neurosci; 1998 Jun; 10(3):219-33. PubMed ID: 9770644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synaptic mechanisms underlying rapid antidepressant action of ketamine.
    Kavalali ET; Monteggia LM
    Am J Psychiatry; 2012 Nov; 169(11):1150-6. PubMed ID: 23534055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does increasing the ratio of AMPA-to-NMDA receptor mediated neurotransmission engender antidepressant action? Studies in the mouse forced swim and tail suspension tests.
    Andreasen JT; Gynther M; Rygaard A; Bøgelund T; Nielsen SD; Clausen RP; Mogensen J; Pickering DS
    Neurosci Lett; 2013 Jun; 546():6-10. PubMed ID: 23643996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond monoamine-based therapies: clues to new approaches.
    Skolnick P
    J Clin Psychiatry; 2002; 63 Suppl 2():19-23. PubMed ID: 15453010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanisms of action of the antidepressants (author's transl)].
    Constantinidis J; Tissot R
    Encephale; 1979; 5(5 Suppl):689-700. PubMed ID: 44870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antidepressants on uptake and receptor systems in the brain.
    Fuller RW; Wong DT
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):485-90. PubMed ID: 2868490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression.
    Skolnick P; Layer RT; Popik P; Nowak G; Paul IA; Trullas R
    Pharmacopsychiatry; 1996 Jan; 29(1):23-6. PubMed ID: 8852530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current perspectives on the development of non-biogenic amine-based antidepressants.
    Skolnick P; Legutko B; Li X; Bymaster FP
    Pharmacol Res; 2001 May; 43(5):411-23. PubMed ID: 11394932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the role of metabotropic glutamate receptors in the mechanisms of action of antidepressants.
    Pałucha A; Pilc A
    Pol J Pharmacol; 2002; 54(6):581-6. PubMed ID: 12866712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamate-based antidepressants: 20 years on.
    Skolnick P; Popik P; Trullas R
    Trends Pharmacol Sci; 2009 Nov; 30(11):563-9. PubMed ID: 19837463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The action of antidepressants on the glutamate system: regulation of glutamate release and glutamate receptors.
    Musazzi L; Treccani G; Mallei A; Popoli M
    Biol Psychiatry; 2013 Jun; 73(12):1180-8. PubMed ID: 23273725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamate and depression: clinical and preclinical studies.
    Paul IA; Skolnick P
    Ann N Y Acad Sci; 2003 Nov; 1003():250-72. PubMed ID: 14684451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of glutamate on the action of antidepressants.
    Hashimoto K
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1558-68. PubMed ID: 20600468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurochemical mechanisms of antidepressant action of new adenine derivative].
    Kovalev DG; Zimin IA; Smirnova LA; Riabukha AF
    Eksp Klin Farmakol; 2010 Dec; 73(12):13-6. PubMed ID: 21395010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of the C-terminal domain of the NR2B subunit alters channel properties and synaptic targeting of N-methyl-D-aspartate receptors in nascent neocortical synapses.
    Mohrmann R; Köhr G; Hatt H; Sprengel R; Gottmann K
    J Neurosci Res; 2002 May; 68(3):265-75. PubMed ID: 12111856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressants. Current concepts of mode of action.
    Léonard BE
    Encephale; 1991; 17 Spec No 1():127-31. PubMed ID: 1677887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamines directly inhibit N-methyl-D-aspartate receptors expressed in Xenopus oocytes in a voltage-dependent manner.
    Masuko T; Suzuki I; Kizawa Y; Kusama-Eguchi K; Watanabe K; Kashiwagi K; Igarashi K; Kusama T
    Neurosci Lett; 2004 Nov; 371(1):30-3. PubMed ID: 15500961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.